What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction?

Europace

Volumn 16, Issue 9, 2014, Pages 1315-1321

  Zaman, Sarah ^a,b   Narayan, Arun ^a   Thiagalingam, Aravinda ^a,b   Sivagangabalan, Gopal ^a,b   Thomas, Stuart ^a,b   Ross, David L ^a,b   Kovoor, Pramesh ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Electrophysiology study; Left ventricular function; Myocardial infarction; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOMORPHIC VENTRICULAR TACHYCARDIA; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RESUSCITATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; TREATMENT OUTCOME; CLINICAL TRIAL; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ECHOGRAPHY; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PREVENTION AND CONTROL; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; AGED; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; FOLLOW UP; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; LIFE EXPECTANCY; ST SEGMENT ELEVATION;

CAUSALITY; COMORBIDITY; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84906983140     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu026     Document Type: Article

References (30)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Richards DA, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 1991;83:756-63.
4. Schmitt C, Barthel P, Ndrepepa G, Schreieck J, Plewan A, Schomig A et al. Value of programmed ventricular stimulation for prophylactic internal cardioverterdefibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol 2001;37:1901-7. (Pubitemid 32499977)
5. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002;106:2466-72. (Pubitemid 35278803)
6. Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH 2nd, Sethuraman B et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 2009;53:471-9.
7. Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 2009;30:689-98.
8. Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation 2009;120:194-200.
9. Bourke JP, Richards DA, Ross DL, Wallace EM, McGuire MA, Uther JB. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol 1991;18:780-8.
10. Kumar S, Sivagangabalan G, Zaman S, West EB, Narayan A, Thiagalingam A et al. Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm 2010;7:1589-97.
11. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8. (Pubitemid 41007844)
12. Ottervanger JP, Ramdat Misier AR, Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT et al. Mortality in patients with left ventricular ejection fraction
13. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA 2008;300:2022-9.
14. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8. (Pubitemid 39603155)
15. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361:1427-36.
16. Zaman S, Kumar S, Narayan A, Sivagangabalan G, Thiagalingam A, Ross DL et al. Induction of ventricular tachycardia with the fourth extrastimulus and its relationship to risk of arrhythmic events in patients with post-myocardial infarct left ventricular dysfunction. Europace 2012;14:1771-7.
17. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982;65:457-64. (Pubitemid 12168347)
18. Chong JJ, Ganesan AN, Eipper V, Kovoor P. Comparison of left ventricular ejection fraction and inducible ventricular tachycardia in ST-elevation myocardial infarction treated by primary angioplasty versus thrombolysis. Am J Cardiol 2008;101:153-7.
19. Ottervanger JP, van't Hof AW, Reiffers S, Hoorntje JC, Suryapranata H, de Boer MJ et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001;22:785-90. (Pubitemid 32625235)
20. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
21. Kimura S, Bassett AL, Gaide MS, Kozlovskis PL, Myerburg RJ. Regional changes in intracellular potassium and sodium activity after healing of experimental myocardial infarction in cats. Circ Res 1986;58:202-8. (Pubitemid 16107744)
22. Hsieh CH, Chia EM, Huang K, Lu J, Barry M, Pouliopoulos J et al. Evolution of ventricular tachycardia and its electrophysiological substrate early after myocardial infarction: an ovine model. Circ Arrhythm Electrophysiol 2013;6:1010-7.
23. Zaman S, Kumar S, Sullivan J, Narayan A, Thiagalingam A, Ross DL et al. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-elevation myocardial infarction. Circ Arrhythm Electrophysiol 2013;6:884-90.
24. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
25. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
26. Every N, Hallstrom A, McDonald KM, Parsons L, Thom D, Weaver D et al. Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am Heart J 2002;144:390-6.
27. Holmgren CM, Nystrom BM, Karlsson TK, Herlitz JD, Edvardsson NG. Presumed arrhythmic death in consecutive survivors of acute myocardial infarction - implications for primary implantable cardioverter defibrillator implantation. Coron Artery Dis 2009;20:155-62.
28. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-53.
29. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83.
30. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-82.